Quote BS LOL, "ONCE appears to be well behind OCAT in whatever other indications
ONCE may have in mind anyway. "
WHAT???????
That's why ONCE (aka Spark Therapeutics, Inc.) has $223 MILLION CASH in their bank account and ZERO DEBT and $4 million in annual sales already versus how much does ole OCAT have, LOL????? And ONCE just completed a PHASE III trial and STILL is flush w/ $220 plus MILLION cash in their bank account and is going for FDA submission/approval as of RIGHT NOW, not in year "maybe" 2019 or 2020 like lil ole OCAT, LOL !!!
EVERY company is supposedly "behind" ole OCATA, all except when it comes to the reality and FACTS of ole OCAT having little success raising capital or attracting CASH in the market place (a $28 million warrant laced secondary versus the $62 million they originally "tried" for and failed to raise and now also are carrying $6 million in DEBT and STILL are relying on a dilution Lincoln credit line for survival cash, etc)- and OCAT barely is out of the starting gate on a phase II trial, after taking FIVE YEARS to complete a micro sized, very tiny phase I, LOL!!
Yeah, it's ONCE, Spark Therapeutics, Inc. w/ their $1.4 BILLION market cap and CASH flush bank account and $57 per share price that is "behind" ole OCATA trading at $4 bucks and small change w/ barely a $150 mil market cap and now DEBT on their books to boot, LOL!!!
Right on. Sure. LOL !!
Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.
AI
